Skip to main content

Table 1

From: PReS-FINAL-2143: Treat-to-target strategy in juvenile idiopathic arthritis: experience in 175 newly-diagnosed patients

 

Inactive disease (ID)

Minimal disease activity (MDA)

Parent-acceptable symptom state (PASS)

JADAS10 ≤ 1 (ID)

JADAS10 ≤ 2/3.8 (MDA)

JADAS10 ≤ 3.5/5.4 (PASS)

6 months

N(%)

50(35.2)

62(43.7)

76(66.1)

43(31.6)

43(31.6)

64(47.1)

12 months

N(%)

48(41)

71(60.7)

77(74.8)

46(41.4)

58(52.3)

66(59.5)

18 months

N(%)

46(47.4)

60(61.9)

69(82.1)

43(46.2)

60(64.5)

67(72)

24 months

N(%)

45(50.6)

5(59.6)

53(70.7)

33(39.3)

40(47.6)

52(61.9)